Join to View Full Profile
1515 Holcombe BlvdHouston, TX 77030
Phone+1 713-792-6161
Dr. Lin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Texas M D Anderson Cancer CenterFellowship, Hematopathology, 1999 - 2000
Yale-New Haven Medical CenterResidency, Pathology-Anatomic and Clinical, 1995 - 1999
Nanjing Medical UniversityClass of 1982
Certifications & Licensure
CA State Medical License 2014 - 2026
TX State Medical License 2003 - 2025
MI State Medical License 1999 - 2006
AR State Medical License 2000 - 2002
American Board of Pathology Anatomic Pathology & Clinical Pathology- American Board of Pathology Hematology
Publications & Presentations
PubMed
- 1 citationsThe Spectrum of B-cell and Plasma Cell Proliferations in Nodal T Follicular Helper Cell Lymphomas.Roman Segura-Rivera, Nicholas Joseph Dcunha, Yiannis Petros Dimopoulos, Aniruddha Mundhada, Tania P Sainz
The American Journal of Surgical Pathology. 2025-03-01 - Single-cell analysis of neoplastic plasma cells identifies myeloma pathobiology mediators and potential targets.Luz Yurany Moreno Rueda, Hua Wang, Keiko Akagi, Minghao Dang, Amishi Vora
Cell Reports. Medicine. 2025-02-18 - Flow cytometric immunophenotypic features of acute myeloid leukemia with mast cell differentiation.Jie Xu, Do Hwan Kim, Wei Wang, Shaoying Li, Pei Lin
American Journal of Clinical Pathology. 2025-02-12
Journal Articles
- Original Contribution Utility of JAK2 V617F Allelic Burden in Distinguishing Chronic Myelomonocytic Leukemia from Primary Myelofibrosis with Monocytosis☆Shaoying Li, L Jeffrey Medeiros, Pei Lin, Srdan Verstovsek, ScienceDirect
- Original Contribution IgM Plasma Cell Myeloma in the Era of Novel Therapy: A Clinicopathologic Study of 17 Cases☆Shaoying Li, Pei Lin, L Jeffrey Medeiros, Guilin Tang, ScienceDirect
Abstracts/Posters
- A Multicenter Phase II Single Arm Trial of Isatuximab in Patients with High Risk Smoldering Multiple Myeloma (HRSMM)Pei Lin, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- A Multicenter Phase II Single Arm Trial of Isatuximab in Patients with High Risk Smoldering Multiple Myeloma (HRSMM)Pei Lin, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Press Mentions
Parkinsons Disease Linked with Most Cancers in TaiwanJune 19th, 2015- Parkinson’s Disease Linked with Most Cancers in TaiwanJune 19th, 2015
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
